
NATURE . COM {
}
Title:
Genomic evolution of metastasis | Nature
Description:
Prognosis for patients with pancreatic cancer is bleak, often owing to late diagnosis. The estimate that at least 15 years pass from tumour initiation to malignancy offers hope for early detection and prevention. See Letters p.1109 & p.1114 Christine Iacobuzio-Donahue and colleagues use whole-genome exome sequencing to analyse primary pancreatic cancers and one or more metastases from the same patients, and find that tumours are composed of distinct subclones. The authors also determine the evolutionary maps by which metastatic cancer clones have evolved within the primary tumour, and estimate the timescales of tumour progression. On the basis of these data, they estimate a mean period of 11.8 years between the initiation of pancreatic tumorigenesis and the formation of the parental, non-metastatic tumour, and a further 6.8 years for the index metastasis clone to arise. These data point to a potentially large window of opportunity during which it might be possible to detect the cancer in a relatively early form. Peter Campbell and colleagues use next-generation sequencing to detect chromosomal rearrangements in 13 patients with pancreatic cancer. The results reveal considerable inter-patient heterogeneity and indicate ongoing genomic instability and evolution during the development of metastases. But for most of the patients studied, more than half of the genetic rearrangements found were present in all metastases and the primary tumour, making them potential targets for therapeutic intervention at early and late stages of the disease.
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {π}
- Health & Fitness
- Animals & Wildlife
- Social Networks
Content Management System {π}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {π}
What is the average monthly size of nature.com audience?
π Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {πΈ}
Display Ads {π―}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {π°}
Display Ads {π―}
$63,100 per month
Estimations show Nature.com's display ad online revenue falls between $42,042 and $115,616 per month.
Keywords {π}
nature, cancer, article, access, content, cookies, pancreatic, privacy, journal, luebeck, open, cas, google, scholar, data, october, genomic, metastasis, research, advertising, information, subscribe, evolution, georg, tumour, institution, articles, buy, ads, permissions, optional, media, personal, parties, policy, journals, log, news, views, published, cite, late, early, detection, prevention, inferring, synteny, genome, assemblies, systematic,
Topics {βοΈ}
nature portfolio permissions reprints privacy policy advertising social media nature 467 nature personal data springerlink instant access data protection permissions genomic instability pancreatic cancer privacy explore content subscription content european economic area malignancy offers hope martin huntΒ &Β isheng institutional subscriptions read potential clinical utility accepting optional cookies journals search log manage preferences cancer metastasis issue learn tumour initiation content access genomic evolution article luebeck article purchase journal publish article cite early detection institution buy optional cookies cancer choices late diagnosis prevention https georg luebeck essential cookies cookies skip institution subscribe articles article genetic evolution usage analysis
Schema {πΊοΈ}
WebPage:
mainEntity:
headline:Genomic evolution of metastasis
description:Prognosis for patients with pancreatic cancer is bleak, often owing to late diagnosis. The estimate that at least 15 years pass from tumour initiation to malignancy offers hope for early detection and prevention. See Letters
p.1109
&
p.1114
Christine Iacobuzio-Donahue and colleagues use whole-genome exome sequencing to analyse primary pancreatic cancers and one or more metastases from the same patients, and find that tumours are composed of distinct subclones. The authors also determine the evolutionary maps by which metastatic cancer clones have evolved within the primary tumour, and estimate the timescales of tumour progression. On the basis of these data, they estimate a mean period of 11.8 years between the initiation of pancreatic tumorigenesis and the formation of the parental, non-metastatic tumour, and a further 6.8 years for the index metastasis clone to arise. These data point to a potentially large window of opportunity during which it might be possible to detect the cancer in a relatively early form. Peter Campbell and colleagues use next-generation sequencing to detect chromosomal rearrangements in 13 patients with pancreatic cancer. The results reveal considerable inter-patient heterogeneity and indicate ongoing genomic instability and evolution during the development of metastases. But for most of the patients studied, more than half of the genetic rearrangements found were present in all metastases and the primary tumour, making them potential targets for therapeutic intervention at early and late stages of the disease.
datePublished:2010-10-27T00:00:00Z
dateModified:2010-10-27T00:00:00Z
pageStart:1053
pageEnd:1055
sameAs:https://doi.org/10.1038/4671053a
keywords:
Cancer genomics
Cancer prevention
Genomic instability
Pancreatic cancer
Science
Humanities and Social Sciences
multidisciplinary
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2F4671053a/MediaObjects/41586_2010_Article_BF4671053a_Fig1_HTML.jpg
isPartOf:
name:Nature
issn:
1476-4687
0028-0836
volumeNumber:467
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:E. Georg Luebeck
affiliation:
name:E. Georg Luebeck is at the Fred Hutchinson Cancer Research Center, Program in Computational Biology, Seattle, Washington 98109-1024, USA. [email protected]
address:
name:E. Georg Luebeck is at the Fred Hutchinson Cancer Research Center, Program in Computational Biology, Seattle, Washington 98109-1024, USA. [email protected],
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:NewsArticle
context:https://schema.org
NewsArticle:
headline:Genomic evolution of metastasis
description:Prognosis for patients with pancreatic cancer is bleak, often owing to late diagnosis. The estimate that at least 15 years pass from tumour initiation to malignancy offers hope for early detection and prevention. See Letters
p.1109
&
p.1114
Christine Iacobuzio-Donahue and colleagues use whole-genome exome sequencing to analyse primary pancreatic cancers and one or more metastases from the same patients, and find that tumours are composed of distinct subclones. The authors also determine the evolutionary maps by which metastatic cancer clones have evolved within the primary tumour, and estimate the timescales of tumour progression. On the basis of these data, they estimate a mean period of 11.8 years between the initiation of pancreatic tumorigenesis and the formation of the parental, non-metastatic tumour, and a further 6.8 years for the index metastasis clone to arise. These data point to a potentially large window of opportunity during which it might be possible to detect the cancer in a relatively early form. Peter Campbell and colleagues use next-generation sequencing to detect chromosomal rearrangements in 13 patients with pancreatic cancer. The results reveal considerable inter-patient heterogeneity and indicate ongoing genomic instability and evolution during the development of metastases. But for most of the patients studied, more than half of the genetic rearrangements found were present in all metastases and the primary tumour, making them potential targets for therapeutic intervention at early and late stages of the disease.
datePublished:2010-10-27T00:00:00Z
dateModified:2010-10-27T00:00:00Z
pageStart:1053
pageEnd:1055
sameAs:https://doi.org/10.1038/4671053a
keywords:
Cancer genomics
Cancer prevention
Genomic instability
Pancreatic cancer
Science
Humanities and Social Sciences
multidisciplinary
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2F4671053a/MediaObjects/41586_2010_Article_BF4671053a_Fig1_HTML.jpg
isPartOf:
name:Nature
issn:
1476-4687
0028-0836
volumeNumber:467
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:E. Georg Luebeck
affiliation:
name:E. Georg Luebeck is at the Fred Hutchinson Cancer Research Center, Program in Computational Biology, Seattle, Washington 98109-1024, USA. [email protected]
address:
name:E. Georg Luebeck is at the Fred Hutchinson Cancer Research Center, Program in Computational Biology, Seattle, Washington 98109-1024, USA. [email protected],
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Nature
issn:
1476-4687
0028-0836
volumeNumber:467
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:E. Georg Luebeck is at the Fred Hutchinson Cancer Research Center, Program in Computational Biology, Seattle, Washington 98109-1024, USA. [email protected]
address:
name:E. Georg Luebeck is at the Fred Hutchinson Cancer Research Center, Program in Computational Biology, Seattle, Washington 98109-1024, USA. [email protected],
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:E. Georg Luebeck
affiliation:
name:E. Georg Luebeck is at the Fred Hutchinson Cancer Research Center, Program in Computational Biology, Seattle, Washington 98109-1024, USA. [email protected]
address:
name:E. Georg Luebeck is at the Fred Hutchinson Cancer Research Center, Program in Computational Biology, Seattle, Washington 98109-1024, USA. [email protected],
type:PostalAddress
type:Organization
PostalAddress:
name:E. Georg Luebeck is at the Fred Hutchinson Cancer Research Center, Program in Computational Biology, Seattle, Washington 98109-1024, USA. [email protected],
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {π}(29)
- What's the financial gain of https://doi.org/10.1186/s12859-018-2026-4?
- What's the profit of https://doi.org/10.1038/bjc.2014.520?
- Learn how profitable https://link.springer.com/article/10.1038/4671053a?utm_source=nature&utm_medium=referral&utm_campaign=buyArticle is on a monthly basis
- https://doi.org/10.1038%2Fnature09460's total income per month
- What's the financial gain of http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2010Natur.467.1109C?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=&journal=Nature&doi=10.1038%2Fnature09460&volume=467&pages=1109-1113&publication_year=2010&author=Campbell%2CPJ
- What are the total earnings of https://doi.org/10.1038%2Fnature09515?
- Monthly income for http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2010Natur.467.1114Y
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=&journal=Nature&doi=10.1038%2Fnature09515&volume=467&pages=1114-1117&publication_year=2010&author=Yachida%2CS
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17247004 making per month?
- How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1209127 generate?
- What's the income of http://scholar.google.com/scholar_lookup?&title=&journal=Genetics&volume=26&pages=234-282&publication_year=1941&author=McClintock%2CB?
- Explore the financials of https://doi.org/10.1038%2Fsj.neo.7900267
- How much revenue does http://scholar.google.com/scholar_lookup?&title=&journal=Neoplasia&doi=10.1038%2Fsj.neo.7900267&volume=4&pages=531-538&publication_year=2002&author=Lo%2CAWI produce monthly?
- Learn about the earnings of https://doi.org/10.1073%2Fpnas.0801151105
- What's http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2008PNAS..10516284M's gross income?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&doi=10.1073%2Fpnas.0801151105&volume=105&pages=16284-16289&publication_year=2008&author=Meza%2CR&author=Jeon%2CJ&author=Moolgavkar%2CSH&author=Luebeck%2CEG bring in?
- How much income does https://citation-needed.springer.com/v2/references/10.1038/4671053a?format=refman&flavour=references have?
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=E.%20Georg%20Luebeck generate?
- How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22E.%20Georg%20Luebeck%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
- How much does https://s100.copyright.com/AppDispatchServlet?title=Genomic%20evolution%20of%20metastasis&author=E.%20Georg%20Luebeck&contentID=10.1038%2F4671053a©right=Springer%20Nature%20Limited&publication=0028-0836&publicationDate=2010-10-27&publisherName=SpringerNature&orderBeanReset=true pull in monthly?
- What's the profit of https://citation-needed.springer.com/v2/references/10.1038/4671053a?format=refman&flavour=citation?
- What is the earnings of https://doi.org/10.1038/s41568-021-00389-3?
- How much revenue does https://doi.org/10.1038/aja.2013.82 produce monthly?
- Income figures for https://doi.org/10.1007/s12307-013-0138-y
- How much does https://www.protocols.io/ bring in each month?
- What are the earnings of https://www.natureindex.com/?
- Explore the financials of http://www.naturechina.com
- Discover the revenue of https://www.natureasia.com/ja-jp
Analytics and Tracking {π}
- Google Tag Manager
Libraries {π}
- Prism.js
- Zoom.js
Emails and Hosting {βοΈ}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk
CDN Services {π¦}
- Crossref